New
and Emerging Technologies: Improved Laboratory and On-Site
Detection of OIE List A Viruses in Animals and Animal Products
Detection of OIE List A Viruses in Animals and Animal Products
Produced by Macom
Sweden 2005-2009
Last updated: June 9 2008
Sweden 2005-2009
Last updated: June 9 2008
The Aim of th Project
The
aim of the LAB-ON-SITE project is to improve the complex diagnosis
of nine diseases on OIE List A:
| Foot-and-mouth disease | FMD* |
| Swine vesicular disease | SVD |
| Vesicular stomatitis | VS |
| Classical swine fever | CSF |
| African swine fever | ASF |
| Bluetongue | BT |
| African horse sickness | AHS |
| Newcastle disease | ND |
| Highly pathogenic avian influenza | HPAI |
*The names of the viruses, causing these diseases, are shown by adding a “V” (like FMDV).
Swine influenza (SI) will also be included, considering the increasing epizootiological and epidemiological importance of this disease and the genetic relation to HPAI.
Intentions for use and impact
The strategic impact of this project is to provide new, robust tests for the front-line diagnosis of OIE List A diseases by developing and applying more rapid and sensitive testing regimes based on recent advances in molecular biology for laboratory use. The combination of the development of rapid, simple pen-side tests, and the application of new advanced high-tech approaches in a single project is novel and will have a high strategic impact. The application of the new methods inside and outside the EU will contribute to more effective epizootiological measures to prevent the entry of these diseases into EU regions and member states. Since OIE List A diseases regularly occur and re-occur in countries around the EU, they represent a permanent threat for the member countries.
The strategic impact of this project is to provide new, robust tests for the front-line diagnosis of OIE List A diseases by developing and applying more rapid and sensitive testing regimes based on recent advances in molecular biology for laboratory use. The combination of the development of rapid, simple pen-side tests, and the application of new advanced high-tech approaches in a single project is novel and will have a high strategic impact. The application of the new methods inside and outside the EU will contribute to more effective epizootiological measures to prevent the entry of these diseases into EU regions and member states. Since OIE List A diseases regularly occur and re-occur in countries around the EU, they represent a permanent threat for the member countries.